NDC 70518-3582-2 - Levetiracetam
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-3582
- Requested NDC
- 70518-3582-2
- Package NDCs from labels
- 70518-3582-2, 70518-3582-0, 70518-3582-5, 70518-3582-4, 70518-3582-3, 70518-3582-6, 70518-3582-8, 70518-3582-7, 70518-3582-1, 70518-3582-9
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2022-12-27
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Levetiracetam - REMEDYREPACK INC. | REMEDYREPACK INC. | 2022-12-27 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levetiracetam | LEVETIRACETAM | REMEDYREPACK INC. | 94d042f7-93b9-43bd-9ace-cfc61903b4d7 | 2026-06-08 | Warnings, Adverse reactions | ANDA079063 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | REMEDYREPACK INC. | 74ccc9f1-b957-4b1b-9464-1b5e3318c916 | 2026-06-08 | Warnings, Adverse reactions | ANDA079063 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | PD-Rx Pharmaceuticals, Inc. | c4b2da6a-ed50-4a54-90bd-32f76b178736 | 2026-06-08 | Warnings, Adverse reactions | 44YRR34555 |
| Chloraseptic Sore Throat Max | PHENOL AND GLYCERIN | Prestige Brands Holdings, Inc. | 882c940c-b3c3-4aa4-8d64-e4260f066ff4 | 2026-06-08 | Warnings | PDC6A3C0OX |
| Levetiracetam | LEVETIRACETAM | Coupler LLC | 53843871-23e3-974e-e063-6394a90a8042 | 2026-06-05 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Cardinal Health 107, LLC | f924d55d-d7ec-4448-b54e-3a7eaf5a1cab | 2026-06-04 | Warnings, Adverse reactions | 44YRR34555 |
| Hemorrhoidal | GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM | HyVee Inc | b867f691-7a13-4659-b664-06aa36899310 | 2026-06-03 | Warnings | PDC6A3C0OX |
| Levetiracetam | LEVETIRACETAM | REMEDYREPACK INC. | c12d8af3-39a8-4690-8d47-43dec70b7579 | 2026-06-01 | Warnings, Adverse reactions | 44YRR34555 |
| C-More Lubricant Eye Drops | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN | PROFOUND NUTRITION LIMITED | 78f04ecb-da5e-468c-81fe-70f7c26b76c2 | 2026-06-01 | Warnings | PDC6A3C0OX |
| Levetiracetam | LEVETIRACETAM | Injecta Medcial LLC | 52fa0eec-3dd9-59ca-e063-6394a90a9791 | 2026-05-29 | Warnings, Adverse reactions | 44YRR34555 |
| Peep Club | GLYCERIN | Peep Club Eyecare Corp. | 513d1988-2827-28d8-e063-6294a90a8d1f | 2026-05-28 | Warnings | PDC6A3C0OX |
| Ripple | GLYCERIN, POVIDONE | CorneaCare Inc | 3b5ba197-d501-681e-e063-6294a90aefb5 | 2026-05-24 | Warnings | PDC6A3C0OX |
| Walgreens Adult Glycerin Laxative | GLYCERIN SUPPOSITORY | Walgreens | 5285403b-ab44-21a1-e063-6394a90a9fd0 | 2026-05-23 | Warnings | PDC6A3C0OX |
| Bacteriostatic Water | BACTERIOSTATIC WATER | Hospira, Inc. | 87d6e9dc-fe3b-4593-ac9a-d7493d1959c7 | 2026-05-22 | Warnings, Adverse reactions | 059QF0KO0R |
| ACD A | CITRIC ACID MONOHYDRATE, DEXTROSE MONOHYDRATE, AND TRISODIUM CITRATE DIHYDRATE | Terumo BCT, Ltd | 8e255bc7-a120-460a-a32d-43931f8115de | 2026-05-21 | Warnings, Adverse reactions | 2968PHW8QP B22547B95K |
| WHITENING SUNSCREENANTI WRINKLE | WHITENING SUNSCREENANTI WRINKLE | Shantou Oushiya Biotechnology Co.,Ltd | 524384e9-b3f8-4c13-e063-6394a90a8973 | 2026-05-20 | Warnings | 059QF0KO0R |
| Levetiracetam | LEVETIRACETAM | Preferred Pharmaceuticals, Inc. | 419b3dba-ae21-4268-ac8b-342aaa609554 | 2026-05-18 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Bryant Ranch Prepack | c4a3018a-3cd8-4e07-a840-099ceae01c91 | 2026-05-15 | Warnings, Adverse reactions | 44YRR34555 |
| HEMORRHOIDAL WITH LIDOCAINE | GLYCERIN, LIDOCAINE, PHENYLEPHRINE HYDROCHLORIDE, WHITE PETROLATUM | CVS PHARMACY, INC | 4d870c68-9e72-464e-b0b8-900d0d661e43 | 2026-05-14 | Warnings | PDC6A3C0OX |
| Levetiracetam | LEVETIRACETAM | Coupler LLC | 51b66893-f7d6-8f9d-e063-6294a90a8e9b | 2026-05-13 | Warnings, Adverse reactions | 44YRR34555 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.